A longitudinal assessment of change in marijuana use with other substance use problems

References

• Compton WM, Han B, Jones CM, Blanco C, Hughes A. Marijuana use and use disorders in adults in the USA, 2002-14: analysis of annual cross-sectional surveys. Lancet Psychiatry. 2016;3:954–64. doi:10.1016/S2215-0366(16)30208-5.
   PubMed Web of Science ®Google Scholar
• Davenport SS, Caulkins JP. Evolution of the United States: marijuana market in the decade of liberalization before full legalization. J Drug Issue. 2016;46:411–17. doi:10.1177/0022042616659759.
   Web of Science ®Google Scholar
• Hasin DS, Wall M, Keyes KM, Cerdá M, Schulenberg J, O’Malley PM, Galea S, Pacula R, Feng T. Medical marijuana laws and adolescent marijuana use in the USA from 1991 to 2014: results from annual, repeated cross-sectional surveys. Lancet Psychiatry. 2015;2:601–08. doi:10.1016/S2215-0366(15)00217-5.
   PubMed Web of Science ®Google Scholar
• Hasin DS, Saha TD, Kerridge BT, Goldstein RB, Chou SP, Zhang H, Jung J, Pickering RP, Ruan WJ, Smith SM, et al. Prevalence of marijuana use disorders in the United States between 2001-2002 and 2012-2013. JAMA Psychiatry. 2015;72:1235–42. doi:10.1001/jamapsychiatry.2015.1858.
   PubMed Web of Science ®Google Scholar
• State policy. Marijuana policy project. [accessed 2018 Feb 28]. https://www.mpp.org/states/.
   Google Scholar
• Choi NG, DiNitto DM, Marti CN. Older-adult marijuana users and ex-users: comparisons of sociodemographic characteristics and mental and substance use disorders. Drug Alcohol Depend. 2016;165:94–102. doi:10.1016/j.drugalcdep.2016.05.023.
   PubMed Web of Science ®Google Scholar
• Cohn A, Villanti A, Richardson A, Rath JM, Williams V, Stanton C, Mermelstein R. The association between alcohol, marijuana use, and new and emerging tobacco products in a young adult population. Addict Behav. 2015;48:79–88. doi:10.1016/j.addbeh.2015.02.005.
   PubMed Web of Science ®Google Scholar
• Agrawal A, Budney AJ, Lynskey MT. The co-occurring use and misuse of cannabis and tobacco: a review. Addiction. 2012;107:1221–33. doi:10.1111/j.1360-0443.2012.03837.x.
   PubMed Web of Science ®Google Scholar
• Swift W, Coffey C, Degenhardt L, Carlin JB, Romaniuk H, Patton GC. Cannabis and progression to other substance use in young adults: findings from a 13-year prospective population-based study. J Epidemiol Community Health. 2012;66(7):e26. doi:10.1136/jech.2010.129056.
   PubMed Web of Science ®Google Scholar
• Tzilos GK, Reddy MK, Caviness CM, Anderson BJ, Stein MD. Getting higher: co-occurring drug use among marijuana-using emerging adults. J Addict Disorder. 2014;33:202–09. doi:10.1080/10550887.2014.950024.
   PubMed Web of Science ®Google Scholar
• Wen H, Hockenberry JM, Cummings JR. The effect of medical marijuana laws on adolescent and adult use of marijuana, alcohol, and other substances. J Health Econ. 2015;42:64–80. doi:10.1016/j.jhealeco.2015.03.007.
   PubMed Web of Science ®Google Scholar
• Persico AM, Bird G, Gabbay FH, Uhl GR. D2 dopamine receptor gene TaqI A1 and B1 restriction fragment length polymorphisms: enhanced frequencies in psychostimulant-preferring polysubstance abusers. Biol Psychiatry. 1996;40:776–84. doi:10.1016/0006-3223(95)00483-1.
   PubMed Web of Science ®Google Scholar
• Uhl GR, Liu QR, Walther D, Hess J, Naiman D. Polysubstance abuse-vulnerability genes: genome scans for association, using 1,004 subjects and 1,494 single-nucleotide polymorphisms. Am J Hum Genet. 2001;69:1290–300. doi:10.1086/324467.
   PubMed Web of Science ®Google Scholar
• Zhang PW, Ishiguro H, Ohtsuki T, Hess J, Carillo F, Walther D, Onaivi ES, Arinami T, Uhl GR. Human cannabinoid receptor 1: 5ʹ exons, candidate regulatory regions, polymorphisms, haplotypes and association with polysubstance abuse. Mol Psychiatry. 2004;9:916–31. doi:10.1038/sj.mp.4001560.
   PubMed Web of Science ®Google Scholar
• Mitchell MR, Potenza MN. Addictions and personality traits: impulsivity and related constructs. Curr Behav Neurosci Rep. 2014;1:1–12. doi:10.1007/s40473-013-0001-y.
   PubMedGoogle Scholar
• Moody L, Franck C, Hatz L, Bickel WK. Impulsivity and polysubstance use: A systematic comparison of delay discounting in mono-, dual-, and trisubstance use. Exp Clin Psychopharmacol. 2016;24:30–37. doi:10.1037/pha0000059.
   PubMed Web of Science ®Google Scholar
• Lopes BM, Gonçalves PD, Ometto M, Dos Santos B, Cavallet M, Chaim-Avancini TM, Serpa MH, Nicastri S, Malbergier A, Busatto GF, et al. Distinct cognitive performance and patterns of drug use among early and late onset cocaine users. Addict Behav. 2017;73:41–47. doi:10.1016/j.addbeh.2017.04.013.
   PubMed Web of Science ®Google Scholar
• Compton WM, Baler R. The epidemiology of DSM-5 cannabis use disorders among U.S. adults: science to inform clinicians working in a shifting social landscape. Am J Psychiatry. 2016;173:551–53. doi:10.1176/appi.ajp.2016.16030314.
   PubMed Web of Science ®Google Scholar
• Zehra A, Burns J, Liu CK, Manza P, Wiers CE, Volkow ND, Wang GJ. Cannabis addiction and the brain: A review. J Neuroimmune Pharmacol. 2018 Mar 19. doi:10.1007/s11481-018-9782-9. [Epub ahead of print].
   PubMedGoogle Scholar
• Manza P, Tomasi D, Volkow ND. Subcortical local functional hyperconnectivity in cannabis dependence. Biol Psychiatry Cogn Neurosci Neuroimaging. 2018;3:285–93. doi:10.1016/j.bpsc.2017.11.004.
   PubMedGoogle Scholar
• Hammond CJ, Mayes LC, Potenza MN. Neurobiology of adolescent substance use and addictive behaviors: treatment implications. Adolesc Med State Art Rev. 2014;25:15–32.
   PubMedGoogle Scholar
• Smart R, Caulkins JP, Kilmer B, Davenport S, Midgette G. Variation in cannabis potency and prices in a newly legal market: evidence from 30 million cannabis sales in Washington state. Addiction. 2017;112:2167–77. doi:10.1111/add.13886.
   PubMed Web of Science ®Google Scholar
• Connor JP, Gullo MJ, White A, Kelly AB. Polysubstance use: diagnostic challenges, patterns of use and health. Curr Opin Psychiatry. 2014;27:269–75. doi:10.1097/YCO.0000000000000069.
   PubMed Web of Science ®Google Scholar
• Copersino ML, Boyd SJ, Tashkin DP, Huestis MA, Heishman SJ, Dermand JC, Simmons MS, Gorelick DA. Quitting among non-treatment-seeking marijuana users: reasons and changes in other substance use. Am J Addict. 2006;15:297–302. doi:10.1080/10550490600754341.
   PubMed Web of Science ®Google Scholar
• Allsop DJ, Dunlop AJ, Saddler C, Rivas GR, McGregor IS, Copeland J. Changes in cigarette and alcohol use during cannabis abstinence. Drug Alcohol Depend. 2014;138:54–60. doi:10.1016/j.drugalcdep.2014.01.022.
   PubMed Web of Science ®Google Scholar
• Peters EN, Hughes JR. Daily marijuana users with past alcohol problems increase alcohol consumption during marijuana abstinence. Drug Alcohol Depend. 2010;106:111–18. doi:10.1016/j.drugalcdep.2009.07.027.
   PubMed Web of Science ®Google Scholar
• Hughes JR, Naud S, Budney AJ, Fingar JR, Callas PW. Attempts to stop or reduce daily cannabis use: an intensive natural history study. Psychol Addict Behav. 2016;30:389–97. doi:10.1037/adb0000155.
   PubMed Web of Science ®Google Scholar
• Interuniversity Consortium for Political and Social Sciences. Population Assessment of Tobacco and Health (PATH) study [United States] public-use files user guide. ICPSR 36498. Ann Arbor, Michigan. 2017. [accessed 2017 Sep 5] http://www.icpsr.umich.edu/icpsrweb/NAHDAP/studies/36498.
   Google Scholar
• Pollard MS, Tucker JS, de la Haye K, Green HD, Kennedy DP. A prospective study of marijuana use and cessation among adolescents. Drug Alcohol Depend. 2014;144:134–40. doi:10.1016/j.drugalcdep.2014.08.019.
   PubMed Web of Science ®Google Scholar
• Castaldelli-Maia JM, Nicastri S, Cerdá M, Kim JH, de Oliveira LG, de Andrade AG, Martins SS. In-transition culture of experimentation with cannabis in Latin American college students: A new role within a potential drug use sequencing pattern. Drug Alcohol Rev. 2018;37:273–81. doi:10.1111/dar.12556.
   PubMed Web of Science ®Google Scholar
• Taylor M, Collin SM, Munafò MR, MacLeod J, Hickman M, Heron J. Patterns of cannabis use during adolescence and their association with harmful substance use behaviour: findings from a UK birth cohort. J Epidemiol Community Health. 2017;71:764–70. doi:10.1136/jech-2016-208503.
   PubMed Web of Science ®Google Scholar
• Nkansah-Amankra S, Minelli M. “Gateway hypothesis” and early drug use: additional findings from tracking a population-based sample of adolescents to adulthood. Drug Alcohol Rev. 2018;37:273–81. doi:10.1111/dar.12556.
   PubMedGoogle Scholar
• Richter L, Pugh BS, Ball SA. Assessing the risk of marijuana use disorder among adolescents and adults who use marijuana. Am J Drug Alcohol Abuse. 2017;43:247–60. doi:10.3109/00952990.2016.1164711.
   PubMed Web of Science ®Google Scholar
• American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 5th. Arlington, VA: American Psychiatric Publishing. 2013.
   Google Scholar
• Allison P Statistical horizons. When can you safely ignore multicollinearity? 2015. [accessed 2018 Jan 2] http://statisticalhorizons.com/multicollinearity.
   Google Scholar
• Compton WM, Dawson DA, Conway KP, Brodsky M, Grant BF. Transitions in illicit drug use status over 3 years: A prospective analysis of a general population sample. Am J Psychiatry. 2013;170:660–70. doi:10.1176/appi.ajp.2012.12060737.
   PubMed Web of Science ®Google Scholar
• Gruber SA, Silveri MM, Dahlgren MK, Yurgelun-Todd DA. Why so impulsive? White matter alterations are associated with impulsivity in chronic marijuana smokers. Exp Clin Psychopharm. 2011;19:231–42. doi:10.1037/a0023034.
   PubMed Web of Science ®Google Scholar
• Lau N, Sales P, Averill S, Murphy F, Sato SO, Murphy S. A safer alternative: cannabis substitution as harm reduction. Drug Alcohol Rev. 2015;34:654–59. doi:10.1111/dar.12275.
   PubMed Web of Science ®Google Scholar
• Lee CM, Neighbors C, Woods BA. Marijuana motives: young adults’ reasons for using marijuana. Addict Behav. 2007;32:1384–94. doi:10.1016/j.addbeh.2006.09.010.
   PubMed Web of Science ®Google Scholar
• Patrick ME, Bray BC, Berglund PA. Reasons for marijuana use among young adults and long-term associations with marijuana use and problems. J Stud Alc Drugs. 2016;77:881–88. doi:10.15288/jsad.2016.77.881.
   PubMed Web of Science ®Google Scholar
• Volkow ND, Swanson JM, Evins AE, DeLisi LE, Meier MH, Gonzalez R, Bloomfield MA, Curran HV, Baler R. Effects of cannabis use on human behavior, including cognition, motivation, and psychosis: A review. JAMA Psychiatry. 2016;73:292–97. doi:10.1001/jamapsychiatry.2015.3278.
   PubMed Web of Science ®Google Scholar
• Morley KI, Lynskey MT, Moran P, Borschmann R, Winstock AR. Polysubstance use, mental health and high-risk behaviours: results from the 2012 global drug survey. Drug Alcohol Rev. 2015;34:427–37. doi:10.1111/dar.12263.
   PubMed Web of Science ®Google Scholar
• De Luca MA, Di Chiara G, Cadoni C, Lecca D, Orsolini L, Papanti D, Corkery J, Schifano F, et al. Cannabis; epidemiological, neurobiological and psychopathological issues: an update. CNS Neurol Disord Drug Targets. 2017;16:598–609. doi:10.2174/1871527316666170413113246.
   PubMed Web of Science ®Google Scholar
• Olthuis JV, Darredeau C, Barrett SP. Substance use initiation: the role of simultaneous polysubstance use. Drug Alcohol Rev. 2013;32:67–71. doi:10.1111/j.1465-3362.2012.00470.x.
   PubMed Web of Science ®Google Scholar
• National Academies of Sciences, Engineering, and Medicine. The health effects of cannabis and cannabinoids: the current state of evidence and recommendations for research. Washington, DC: The National Academies Press; 2017. doi:10.17226/24625.
   Google Scholar
• Reiman A, Welty M, Solomon P. Cannabis as a substitute for opioid-based pain medication: patient self-report. Cannabis Cannabinoid Res. 2017;2:160–66. doi:10.1089/can.2017.0012.
   PubMedGoogle Scholar
• Corroon JM Jr, Mischley LK, Sexton M. Cannabis as a substitute for prescription drugs – a cross-sectional study. J Pain Res. 2017;10:989–98. doi:10.2147/JPR.S134330.
   PubMed Web of Science ®Google Scholar
• Lucas P, Walsh Z. Medical cannabis access, use, and substitution for prescription opioids and other substances: A survey of authorized medical cannabis patients. Int J Drug Policy. 2017;42:30–35. doi:10.1016/j.drugpo.2017.01.011.
   PubMed Web of Science ®Google Scholar
• Choi NG, DiNitto DM, Marti CN. Nonmedical versus medical marijuana use among three age groups of adults. Am J Addict. 2017;26:697–706. doi:10.1111/ajad.12598.
   PubMed Web of Science ®Google Scholar
• Nutt DJ, King LA, Phillips LD. Independent scientific committee on drugs. Drug harms in the UK: A multicriteria decision analysis. Lancet. 2010;376(9752):1558–65. doi:10.1016/S0140-6736(10)61462-6.
   PubMed Web of Science ®Google Scholar
• Schauer GL, King BA, Bunnell RE, Promoff G, McAfee TA. Toking, vaping, and eating for health or fun: marijuana use patterns in adults, U.S., 2014. Am J Prev Med. 2016;50:1–8. doi:10.1016/j.amepre.2015.05.027.
   PubMed Web of Science ®Google Scholar
• Prochaska JO, DiClemente CC, Norcross JC. In search of how people change: applications to addictive behaviors. Am Psychol. 1992;47:1102–14. doi:10.1037/0003-066X.47.9.1102.
   PubMed Web of Science ®Google Scholar
• Miller WR, Rollnick S. Motivational interviewing: helping people change. 3rd. New York: Guildford Press. 2012.
   Google Scholar